Total Payments
$818.57
2023 Payments
$390.00
Companies
11
Transactions
32
Medicare Patients
611
Medicare Billing
$36,224
Payment Breakdown by Category
Food & Beverage$468.57 (57.2%)
Consulting$350.00 (42.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $468.57 | 31 | 57.2% |
| Consulting Fee | $350.00 | 1 | 42.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $447.66 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $135.86 | 9 | $0 (2022) |
| Novo Nordisk Inc | $52.07 | 2 | $0 (2023) |
| Genentech USA, Inc. | $43.93 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $42.82 | 3 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $28.26 | 2 | $0 (2021) |
| Mannkind Corporation | $15.11 | 1 | $0 (2022) |
| Lilly USA, LLC | $14.40 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $13.59 | 1 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $12.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $390.00 | 2 | ABBVIE INC. ($350.00) |
| 2022 | $120.38 | 7 | ABBVIE INC. ($44.83) |
| 2021 | $308.19 | 23 | GlaxoSmithKline, LLC. ($105.52) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 03/02/2023 | ABBVIE INC. | SKYRIZI (Biological) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardio-renal | ||||||
| 04/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/16/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Virology & Specialty Care | ||||||
| 12/13/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: Virology & Specialty Care | ||||||
| 11/18/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Virology & Specialty Care | ||||||
| 11/04/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Virology & Specialty Care | ||||||
| 11/01/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: Virology & Specialty Care | ||||||
| 09/22/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 330 | 520 | $60,123 | $19,137 |
| 2022 | 10 | 281 | 510 | $43,512 | $17,088 |
Total Patients
611
Total Services
1,030
Medicare Billing
$36,224
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 93 | $20,276 | $7,048 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $16,127 | $4,679 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 55 | $8,184 | $2,672 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,877 | $2,130 | 24.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 38 | 40 | $4,000 | $1,385 | 34.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 32 | 66 | $2,022 | $1,071 | 52.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 15 | $502.20 | $95.77 | 19.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 21 | $104.58 | $46.20 | 44.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 140 | $30.80 | $10.78 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 50 | $10,901 | $4,614 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,899 | $2,946 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $8,444 | $2,631 | 31.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 56 | 60 | $6,000 | $2,471 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $4,380 | $2,079 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $3,422 | $1,303 | 38.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 24 | 48 | $1,589 | $778.56 | 49.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 22 | $736.56 | $202.02 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 19 | $94.62 | $41.80 | 44.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 20 | 210 | $46.20 | $20.15 | 43.6% |
About Billy Catlett, FNP
Billy Catlett, FNP is a Nurse Practitioner healthcare provider based in Lake Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1538449780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Billy Catlett, FNP has received a total of $818.57 in payments from pharmaceutical and medical device companies, with $390.00 received in 2023. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($468.57).
As a Medicare-enrolled provider, Catlett has provided services to 611 Medicare beneficiaries, totaling 1,030 services with total Medicare billing of $36,224. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Lake Worth, TX
- Active Since 08/19/2011
- Last Updated 03/05/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1538449780
Products in Payments
- SKYRIZI (Biological) $350.00
- TRELEGY ELLIPTA (Drug) $116.77
- VRAYLAR (Drug) $97.66
- Xofluza (Drug) $43.93
- FARXIGA (Drug) $42.82
- Edarbi (Drug) $28.26
- SHINGRIX (Biological) $19.09
- AFREZZA (Drug) $15.11
- JARDIANCE (Drug) $14.40
- BELSOMRA (Drug) $13.59
- Kerendia (Drug) $12.99
- Ozempic (Drug) $12.07
- Doc Band (Device) $11.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lake Worth
Carolina Hernandez
Nurse Practitioner — Payments: $2,446
Nurse Practitioner $2,446
Stephanie Victoria, Aprn, APRN
Nurse Practitioner — Payments: $1,520
Nurse Practitioner $1,520
Claudie Williams, Aprn, APRN
Nurse Practitioner — Payments: $1,153
Nurse Practitioner $1,153
Kimberly France, Arnp, ARNP
Nurse Practitioner — Payments: $1,071
Nurse Practitioner $1,071
Mary Brown, Arnp, ARNP
Nurse Practitioner — Payments: $1,069
Nurse Practitioner $1,069
April Roemer, Aprn, APRN
Nurse Practitioner — Payments: $930.00
Nurse Practitioner $930.00